New hope for tough myeloma: experimental drug cevostamab tested in 355 patients
NCT ID NCT03275103
First seen Nov 17, 2025 · Last updated May 08, 2026 · Updated 21 times
Summary
This early-phase trial tested an experimental drug called cevostamab in 355 people with multiple myeloma that had returned or stopped responding to other treatments. The main goal was to check the drug's safety and find the right dose. While not a cure, the study aims to help control the disease in patients who have few other options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
City of Hope
Duarte, California, 91010, United States
-
Clinica Universidad de Navarra
Pamplona/iruña, Navarre, 31008, Spain
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hospital Clinico Universitario de Salamanca
Salamanca, 37007, Spain
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Mayo Clinic Hospital - Arizona
Scottsdale, Arizona, 85259, United States
-
Memorial Sloan Kettering
New York, New York, 10065, United States
-
Mount Sinai Hospital
New York, New York, 10128, United States
-
Peter MacCallum Cancer Center
East Melbourne, Victoria, 3022, Australia
-
Princess Margaret Cancer Center
Toronto, Ontario, M5G 2M9, Canada
-
Tennessee Oncology - Nashville
Nashville, Tennessee, 37203, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030-4009, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
University of Calgary Cumming School of Medicine
Calgary, Alberta, T2N 4N2, Canada
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.